Next, we investigated the regulatory mechanism responsible for the increased levels of cell cycle inhibitors p21 and p16 and secreted mediators IGFBP3 and PAI-1 in the DM1 model cells. This evidence concerns the gene CDKN1A and myotonic dystrophy type 1.